Invivyd Inc has a consensus price target of $7.8, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from Guggenheim, Morgan Stanley, and HC Wainwright & Co. on April 5, 2024, March 26, 2024, and March 25, 2024. With an average price target of $11.33 between Guggenheim, Morgan Stanley, and HC Wainwright & Co., there's an implied 403.70% upside for Invivyd Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/05/2024 | IVVD | Buy Now | Invivyd | $2.25 | 300% | Guggenheim | Evan Wang | → $9 | Upgrade | Neutral → Buy | Get Alert |
03/26/2024 | IVVD | Buy Now | Invivyd | $2.25 | 344.44% | Morgan Stanley | Maxwell Skor | $4 → $10 | Upgrade | Equal-Weight → Overweight | Get Alert |
03/25/2024 | IVVD | Buy Now | Invivyd | $2.25 | 566.67% | HC Wainwright & Co. | Patrick Trucchio | → $15 | Reiterates | Buy → Buy | Get Alert |
01/18/2024 | IVVD | Buy Now | Invivyd | $2.25 | 566.67% | HC Wainwright & Co. | Patrick Trucchio | $5 → $15 | Maintains | Buy | Get Alert |
12/19/2023 | IVVD | Buy Now | Invivyd | $2.25 | 77.78% | Morgan Stanley | Jeffrey Hung | $1 → $4 | Upgrade | Underweight → Equal-Weight | Get Alert |
08/14/2023 | IVVD | Buy Now | Invivyd | $2.25 | 122.22% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Reiterates | Buy → Buy | Get Alert |
07/18/2023 | IVVD | Buy Now | Invivyd | $2.25 | 122.22% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Reiterates | Buy → Buy | Get Alert |
06/23/2023 | IVVD | Buy Now | Invivyd | $2.25 | 122.22% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Reiterates | Buy → Buy | Get Alert |
05/15/2023 | IVVD | Buy Now | Invivyd | $2.25 | 122.22% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Reiterates | Buy → Buy | Get Alert |
05/01/2023 | IVVD | Buy Now | Invivyd | $2.25 | 122.22% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Initiates | → Buy | Get Alert |
03/27/2023 | IVVD | Buy Now | Invivyd | $2.25 | -55.56% | Morgan Stanley | Matthew Harrison | $2 → $1 | Maintains | Underweight | Get Alert |
01/24/2023 | IVVD | Buy Now | Invivyd | $2.25 | -11.11% | Morgan Stanley | Matthew Harrison | $3 → $2 | Maintains | Underweight | Get Alert |
09/14/2022 | IVVD | Buy Now | Invivyd | $2.25 | 33.33% | Morgan Stanley | Matthew Harrison | → $3 | Maintains | Underweight | Get Alert |
The latest price target for Invivyd (NASDAQ: IVVD) was reported by Guggenheim on April 5, 2024. The analyst firm set a price target for $9.00 expecting IVVD to rise to within 12 months (a possible 300.00% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for Invivyd (NASDAQ: IVVD) was provided by Guggenheim, and Invivyd upgraded their buy rating.
The last upgrade for Invivyd Inc happened on April 5, 2024 when Guggenheim raised their price target to $9. Guggenheim previously had a neutral for Invivyd Inc.
There is no last downgrade for Invivyd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Invivyd, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Invivyd was filed on April 5, 2024 so you should expect the next rating to be made available sometime around April 5, 2025.
While ratings are subjective and will change, the latest Invivyd (IVVD) rating was a upgraded with a price target of $0.00 to $9.00. The current price Invivyd (IVVD) is trading at is $2.25, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.